Literature DB >> 8158888

Prevention of progression in non-diabetic chronic renal failure.

G J Becker1, J A Whitworth, B U Ihle, S Shahinfar, P S Kincaid-Smith.   

Abstract

We have performed separate randomized prospective controlled studies on the effects of protein-restricted diet and angiotensin converting enzyme (ACE) inhibition on the rate of progression of non-diabetic renal failure. Renal function was assessed by creatinine clearance, reciprocal of plasma creatinine concentration and 51Cr-EDTA clearance. A protein-restricted diet (0.4 g per kg) resulted in a significantly lower rate of progression, as assessed by the slope of these parameters with time, when compared with a standard diet. ACE inhibition, when assessed by a mixed effect model, also significantly reduced the rate of progression. The many variables involved hinder trials of therapies directed against progression in non-diabetic renal failure.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8158888

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  4 in total

Review 1.  Recognition and management of IgA nephropathy.

Authors:  L S Ibels; A Z Gyory; R J Caterson; C A Pollock; J F Mahony; D A Waugh; S Coulshed
Journal:  Drugs       Date:  1998-01       Impact factor: 9.546

2.  To pay or not to pay? A decision and cost-utility analysis of angiotensin-converting-enzyme inhibitor therapy for diabetic nephropathy.

Authors:  W F Clark; D N Churchill; L Forwell; G Macdonald; S Foster
Journal:  CMAJ       Date:  2000-01-25       Impact factor: 8.262

3.  Low protein diets for non-diabetic adults with chronic kidney disease.

Authors:  Deirdre Hahn; Elisabeth M Hodson; Denis Fouque
Journal:  Cochrane Database Syst Rev       Date:  2018-10-04

4.  Low protein diets for non-diabetic adults with chronic kidney disease.

Authors:  Deirdre Hahn; Elisabeth M Hodson; Denis Fouque
Journal:  Cochrane Database Syst Rev       Date:  2020-10-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.